ARCHIVES

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve Plan For Repository For Prostate Cancer Issue Specimens

March 19, 1999

CMS To Recognize NCCN’s Drug Compendium.

June 6, 2008

GAO Study Finds Lumpectomy Effective As Mastectomy In Trials And In Practice

November 25, 1994

NSABP Executive Committee Joins Fisher In Suit Against Pitt

August 5, 1994

Radiation Therapy Combination Better For Treating Cancer Spread To Brain

May 28, 2004

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002